These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32063591)

  • 21. International Reporting Mechanism for Unethical Germline Gene Editing Experiments Is Needed.
    Schaefer GO; Labude MK; Zhu Y; Foo RS; Xafis V
    Trends Biotechnol; 2021 May; 39(5):427-430. PubMed ID: 33160679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Should We Regulate Heritable Human Genome Editing in Australia?
    Nicol D; Rudge C; Paxton R; Niemeyer S
    J Law Med; 2022 Jun; 29(2):322-336. PubMed ID: 35819374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline gene editing and the precautionary principle.
    Koplin JJ; Gyngell C; Savulescu J
    Bioethics; 2020 Jan; 34(1):49-59. PubMed ID: 31247677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Democratic Governance of Human Germline Genome Editing.
    Jasanoff S; Hurlbut JB; Saha K
    CRISPR J; 2019 Oct; 2(5):266-271. PubMed ID: 31599682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Developments in the Regulation of Heritable Human Genome Editing.
    Soni S
    J Bioeth Inq; 2024 Mar; 21(1):15-18. PubMed ID: 38568398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial heritable genome editing: mapping a responsible pathway from basic research to the clinic.
    Ranisch R; Trettenbach K; Arnason G
    Med Health Care Philos; 2023 Mar; 26(1):21-35. PubMed ID: 36414813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating Demand for Germline Genome Editing: An
    Viotti M; Victor AR; Griffin DK; Groob JS; Brake AJ; Zouves CG; Barnes FL
    CRISPR J; 2019 Oct; 2(5):304-315. PubMed ID: 31599685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eight Strategies to Engineer Acceptance of Human Germline Modifications.
    Khan S; Drabiak K
    J Bioeth Inq; 2024 Mar; 21(1):81-94. PubMed ID: 37523056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Societal and Ethical Impacts of Germline Genome Editing: How Can We Secure Human Rights?
    Halpern J; O'Hara SE; Doxzen KW; Witkowsky LB; Owen AL
    CRISPR J; 2019 Oct; 2(5):293-298. PubMed ID: 31599687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactions to the National Academies/Royal Society Report on
    Angrist M; Barrangou R; Baylis F; Brokowski C; Burgio G; Caplan A; Chapman CR; Church GM; Cook-Deegan R; Cwik B; Doudna JA; Evans JH; Greely HT; Hercher L; Hurlbut JB; Hynes RO; Ishii T; Kiani S; Lee LH; Levrier G; Liu DR; Lunshof JE; Macintosh KL; Mathews DJH; Meslin EM; Mills PHR; Montoliu L; Musunuru K; Nicol D; O'Neill H; Qiu R; Ranisch R; Sherkow JS; Soni S; Terry S; Topol E; Williamson R; Zhang F; Davies K
    CRISPR J; 2020 Oct; 3(5):332-349. PubMed ID: 33095048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focusing on Human Rights: a framework for CRISPR germline genome editing ethics and regulation.
    Doxzen K; Halpern J
    Perspect Biol Med; 2020; 63(1):44-53. PubMed ID: 32063585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What Is Prudent Governance of Human Genome Editing?
    Schweikart SJ
    AMA J Ethics; 2019 Dec; 21(12):E1042-1048. PubMed ID: 31876467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should human germ line editing be allowed? Some suggestions on the basis of the existing regulatory framework.
    de Miguel Beriain I
    Bioethics; 2019 Jan; 33(1):105-111. PubMed ID: 30080925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of scientific self-regulation for the control of genome editing in the human germline: The lessons from the Asilomar and the Napa meetings show how self-regulation and public deliberation can lead to regulation of new biotechnologies.
    Gregorowius D; Biller-Andorno N; Deplazes-Zemp A
    EMBO Rep; 2017 Mar; 18(3):355-358. PubMed ID: 28219901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene editing in human development: ethical concerns and practical applications.
    Rossant J
    Development; 2018 Jul; 145(16):. PubMed ID: 30045910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shaping the CRISPR Gene-Editing Debate: Questions About Enhancement and Germline Modification.
    Johnston J
    Perspect Biol Med; 2020; 63(1):141-154. PubMed ID: 32063593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fearful old world? A commentary on the Second International Summit on human genome editing.
    Greenfield A
    Mamm Genome; 2019 Feb; 30(1-2):1-4. PubMed ID: 30600355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective.
    Nordberg A; Minssen T; Feeney O; de Miguel Beriain I; Galvagni L; Wartiovaara K
    Bioethics; 2020 Jan; 34(1):16-32. PubMed ID: 31877579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene-edited babies: What went wrong and what could go wrong.
    Wang H; Yang H
    PLoS Biol; 2019 Apr; 17(4):e3000224. PubMed ID: 31039144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproductive medicine involving genome editing: clinical uncertainties and embryological needs.
    Ishii T
    Reprod Biomed Online; 2017 Jan; 34(1):27-31. PubMed ID: 27743815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.